274 related articles for article (PubMed ID: 26262503)
1. Oral Platelet-Derived Growth Factor and Vascular Endothelial Growth Factor Inhibitor Sunitinib Prevents Chronic Allograft Injury in Experimental Kidney Transplantation Model.
Rintala JM; Savikko J; Palin N; Rintala SE; Koskinen PK; von Willebrand E
Transplantation; 2016 Jan; 100(1):103-10. PubMed ID: 26262503
[TBL] [Abstract][Full Text] [Related]
2. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
Savikko J; Taskinen E; Von Willebrand E
Transplantation; 2003 Apr; 75(8):1147-53. PubMed ID: 12717194
[TBL] [Abstract][Full Text] [Related]
3. Sunitinib, a small-molecule receptor tyrosine kinase inhibitor, suppresses neointimal hyperplasia in balloon-injured rat carotid artery.
Ishii S; Okamoto Y; Katsumata H; Egawa S; Yamanaka D; Fukushima M; Minami S
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):359-66. PubMed ID: 23324994
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Venous Neointimal Hyperplasia by a Multitarget Receptor Tyrosine Kinase Inhibitor.
Kwon SH; Li L; He Y; Tey CS; Li H; Zhuplatov I; Kim SJ; Terry CM; Blumenthal DK; Shiu YT; Cheung AK
J Vasc Res; 2015; 52(4):244-256. PubMed ID: 26788996
[TBL] [Abstract][Full Text] [Related]
5. Early induction of platelet-derived growth factor ligands and receptors in acute rat renal allograft rejection.
Savikko J; Kallio EA; von Willebrand E
Transplantation; 2001 Jul; 72(1):31-7. PubMed ID: 11468531
[TBL] [Abstract][Full Text] [Related]
6. The effect of acute rejection and cyclosporin A-treatment on induction of platelet-derived growth factor and its receptors during the development of chronic rat renal allograft rejection.
Savikko J; Kallio EA; Taskinen E; von Willebrand E
Transplantation; 2002 Feb; 73(4):506-11. PubMed ID: 11889420
[TBL] [Abstract][Full Text] [Related]
7. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
Rintala SE; Savikko J; Rintala JM; von Willebrand E
Transplant Proc; 2006 Dec; 38(10):3236-8. PubMed ID: 17175233
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor inhibition, a novel pathway to prevent chronic allograft injury.
Rintala JM; Savikko J; Palin N; Rintala SE; Koskinen PK; von Willebrand E
Transplantation; 2014 Oct; 98(8):821-7. PubMed ID: 25073034
[TBL] [Abstract][Full Text] [Related]
10. Early short-term platelet-derived growth factor inhibition prevents the development of chronic allograft nephropathy in experimental rat kidney transplantation.
Savikko J; Rintala J; von Willebrand E
Transplant Proc; 2006 Dec; 38(10):3231-2. PubMed ID: 17175231
[TBL] [Abstract][Full Text] [Related]
11. Phloretin Inhibits Platelet-derived Growth Factor-BB-induced Rat Aortic Smooth Muscle Cell Proliferation, Migration, and Neointimal Formation After Carotid Injury.
Wang D; Wang Q; Yan G; Qiao Y; Tang C
J Cardiovasc Pharmacol; 2015 May; 65(5):444-55. PubMed ID: 25945863
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor inhibition by erlotinib prevents vascular smooth muscle cell and monocyte-macrophage function in vitro.
Savikko J; Rintala JM; Rintala S; Koskinen P
Transpl Immunol; 2015 Jun; 32(3):175-8. PubMed ID: 25791345
[TBL] [Abstract][Full Text] [Related]
13. Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo.
Schwaiberger AV; Heiss EH; Cabaravdic M; Oberan T; Zaujec J; Schachner D; Uhrin P; Atanasov AG; Breuss JM; Binder BR; Dirsch VM
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2475-81. PubMed ID: 20847306
[TBL] [Abstract][Full Text] [Related]
14. Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.
Nykänen AI; Krebs R; Tikkanen JM; Raisky O; Sihvola R; Wood J; Koskinen PK; Lemström KB
Transplantation; 2005 Jan; 79(2):182-9. PubMed ID: 15665766
[TBL] [Abstract][Full Text] [Related]
15. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells.
Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ
Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388
[TBL] [Abstract][Full Text] [Related]
16. A novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model.
Huang C; Mei H; Zhou M; Zheng X
Mol Med Rep; 2017 Jan; 15(1):21-28. PubMed ID: 27922693
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.
Nurminskaya M; Beazley KE; Smith EP; Belkin AM
J Vasc Res; 2014; 51(6):418-28. PubMed ID: 25612735
[TBL] [Abstract][Full Text] [Related]
18. Different effects of tacrolimus and cyclosporine on PDGF induction and chronic allograft injury: evidence for improved kidney graft outcome.
Savikko J; Teppo AM; Taskinen E; von Willebrand E
Transpl Immunol; 2014 Sep; 31(3):145-51. PubMed ID: 25158212
[TBL] [Abstract][Full Text] [Related]
19. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Transplant Proc; 2006 Oct; 38(8):2719-21. PubMed ID: 17098049
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer of redox factor-1 inhibits neointimal formation: involvement of platelet-derived growth factor-beta receptor signaling via the inhibition of the reactive oxygen species-mediated Syk pathway.
Lee HM; Jeon BH; Won KJ; Lee CK; Park TK; Choi WS; Bae YM; Kim HS; Lee SK; Park SH; Irani K; Kim B
Circ Res; 2009 Jan; 104(2):219-27, 5p following 227. PubMed ID: 19038866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
